Medical Technology Stock Letter

BioInvest.com is the web home of the Medical Technology Stock Letter, an industry leading newsletter covering the biotech sector for almost thirty years.  Seeking information on FDA Approvals, Biotech Mergers & Acquisitions, Stock Picks, Long Investments and the occassional Short Sale?  Trying to stay on the cutting edge of scientific developments so you can stay ahead of the Markets? 

The Medical Technology Stock Letter is the source for Biotechnology news and investing advice.  Forget the pundits and the trends.  Here you find only experienced insight and the details that Wall Street doesn't want you to know.

Request a Free Issue then go to the Newsletter page to find out what's new at MTSL.

Subscribers, click here to log in or go directly to the Subscriber area.

Search BioInvest.com
Loading
Latest News from Yahoo! Finance

July 8, 2010

DateThursday, July 8, 2010 at 12:02PM

In the Model Portfolio we will sell 5,000 shares of IMGN and short VVUS with the proceeds. In the Trader’s Portfolio we will sell 1,875 IMGN and short VVUS with the proceeds. All transactions will use Monday, July 12 closing prices. A 1% commission will be charged on each transaction.

AuthorAdministrator | Comments Off |